This study found that inserting follicular units in a specific direction during hair restoration surgery did not improve natural-looking outcomes, as hair could be styled freely with regular combing.
6 citations
,
January 2010 in “Actas Dermo-Sifiliográficas”
This review covers the current procedure for follicularunit hair transplantation, noting that recent advancements have made the results natural and undetectable, but it presents no new experimental findings.
May 2026 in “International Journal of Drug Delivery Technology”
This study found that infiltrating dilute adrenaline into the recipient area during implanter-based FUE hair transplantation significantly reduced intraoperative bleeding, improving graft precision and visualization, without major safety concerns among the 50 patients observed.
In this study, male patients with stage III-IV androgenetic alopecia who underwent hair transplantation using a technique that considers the direction and angle of hair growth reported a 19.7% increase in satisfaction regarding the naturalness of their results.
Curved hair transplantation requires specialized tools and techniques to avoid damaging hair follicles, with modified FUE being the preferred method. Proper extraction and implantation angles are crucial to prevent complications like keloids and sterile folliculitis.
Longitudinal partial follicularunit transplantation involves extracting part of the donor follicularunit, allowing the donor area to be overharvested without noticeable hair loss. The conversation questions if this method is practiced in clinics or if it's theoretical, and whether it relates to hair cloning or multiplication.
Longitudinal partial follicularunit transplantation involves extracting part of the donor follicularunit, allowing the donor area to maintain hair production and potentially increasing transplant yield. The conversation questions if this method is practiced in clinics or remains theoretical, and whether it relates to hair cloning or multiplication.
PP405, a topical treatment, shows promise for hair growth by activating inactive follicles, with 66% of participants experiencing positive results. The treatment is well-tolerated and may proceed directly to Phase 3 trials, offering a potential alternative to minoxidil and finasteride.
Pelage Pharmaceuticals' PP405 aims to treat hair loss by reactivating dormant hair follicle stem cells, showing promising results in early trials. The company plans to present their findings at the American Academy of Dermatology Annual Meeting in 2026.